Stada Boosted By Consumer And Specialty Growth
As Generics Business Also Delivers Solid Improvement In 2022
Executive Summary
Stada has celebrated “growing faster than the markets in which it operates” after delivering a 2022 performance that saw the firm’s earnings lifted in particular by increases in its consumer healthcare and specialty segments.